Bhakuni, R., Hall, E. T., Ansstas, G., Bhatia, S., Brohl, A. S., Burgess, M. A., Dimitrova, M., Gao, L., Ishizuka, J. J., Lipson, E. J., Lutzky, J., Silk, A. W., Yun, J., Brownell, I., Murray, J., Mowery, Y. M., Gooley, T., Gore, S., Topalian, S. L., Nghiem, P. (2025). The MATRiX trial: A multicenter, randomized, phase II study of ATR inhibition (via tuvusertib) with or without avelumab in patients with advanced anti-PD-(L)1–refractory Merkel cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps9598